Truist Financial restated their buy rating on shares of American Healthcare REIT (NYSE:AHR – Free Report) in a report published on Monday, Benzinga reports. The brokerage currently has a $17.00 price target on the stock.
A number of other equities analysts have also recently weighed in on AHR. Morgan Stanley started coverage on American Healthcare REIT in a report on Monday, March 4th. They issued an overweight rating and a $17.00 price target for the company. KeyCorp started coverage on American Healthcare REIT in a research note on Monday, March 4th. They set an overweight rating and a $16.00 price objective for the company. Citigroup started coverage on American Healthcare REIT in a research note on Monday, March 4th. They set a neutral rating and a $14.00 price objective for the company. Barclays started coverage on American Healthcare REIT in a research note on Thursday, March 14th. They set an overweight rating and a $18.00 price objective for the company. Finally, JMP Securities reiterated a market outperform rating and set a $16.00 price objective on shares of American Healthcare REIT in a research note on Monday. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of Moderate Buy and an average price target of $16.00.
View Our Latest Analysis on AHR
American Healthcare REIT Price Performance
American Healthcare REIT Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 19th. Stockholders of record on Thursday, March 28th will be given a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.96%.
Insider Activity
In related news, Director Mathieu B. Streiff purchased 83,333 shares of the company’s stock in a transaction dated Friday, February 9th. The stock was acquired at an average cost of $12.00 per share, for a total transaction of $999,996.00. Following the completion of the transaction, the director now directly owns 90,740 shares of the company’s stock, valued at $1,088,880. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
About American Healthcare REIT
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
See Also
- Five stocks we like better than American Healthcare REIT
- The 3 Best Fintech Stocks to Buy Now
- Best Bear Market Funds: Top 3 Investment Options to Consider
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.